The Edith and Benson Ford Heart & Vascular Institute has announced it will auction a one-of-a-kind 2013 Shelby GT500 Mustang (Lot# 3008)at 3 p.m. on Friday January 18, 2013 at the upcoming Barrett-Jackson Auction in Scottsdale, Ariz. The car, which was created by Ford designer Melvin Betancourt, a former cardiac patient who feels that he owes his life to a dedicated team of heart surgeons at Henry Ford Hospital in Detroit, is sure to generate much attention.
In an effort to thank the dedicated team at Henry Ford Hospital, Betancourt focused all of his design talents on creating this special Mustang. The custom GT500 features a stunning white exterior paint scheme with contrasting white graphics and 20-inch white wheels. In addition, the car’s cockpit features white leather Recaro seats stitched with a black contrast thread for an overall design theme that is worthy of this car’s outstanding heritage.
“Even with his rich racing pedigree, it’s hard to imagine what Henry Ford might have thought had he ever encountered such a massively powerful vehicle as the 2013 Shelby GT500,” said John Felice, general manager Ford and Lincoln Marketing. “However, we’re fairly certain he’d be thrilled that the vehicle carried the Ford oval and that it was being auctioned to support the critically important work of saving lives.”
The Mustang has been signed by Edsel B. Ford II, William C. Ford, Jr., and Alan Mulally, CEO of Ford Motor Company. It boasts 662 horsepower and has a top speed of more than 200 mph.
The car is estimated to sell between $150,000 and $250,000.
You can learn more about the auction, registering to bid, and Speed TV’s live coverage schedule by visiting www.barrett-jackson.com.
About the Edith and Benson Ford Heart & Vascular Institute
With a history that spans more than 90 years, the institute has earned international recognition as a leader and innovator in comprehensive cardiovascular care, research and education. Established in 1946, the cardiac training program is one of the longest running in the U.S., and the first in Michigan. The program is one of only three in Michigan for advanced heart failure treatment options and one of the few programs in the U.S. offering robotically assisted laparoscopic aortic surgery.